Lillia’s clinically proven, AI-powered platform enables healthcare providers, insurers, corporations and public sector entities to manage chronic diseases effectively.
Sujit Chakrabarty, Lillia’s founder and CEO, said in a statement, “Diabetes and related chronic conditions is the world’s biggest healthcare challenge affecting more than 500 million people. The good news is with the right interventions, diabetes can be prevented and reversed in the early stages, or effectively managed for long-term health. Lillia exists to lower the chronic disease burden for the world by providing continuous adaptive care that drives a real and lasting lifestyle change.”
Lillia leverages AI, paired with expert human coaches—psychologists, nutritionists and doctors, to create a care journey hyperlocalised to an individual’s metabolism and lifestyle. It guides them to develop long-lasting micro-habits backed by proven clinical outcomes.
At Web Summit Qatar, Lillia also unveiled its vision of a chronic care digital twin paired with AI agents to bring predictive capabilities to the platform and unlock applications in real-time risk monitoring and precision medication, among other use cases.
Lillia also announced it has received a $1.7 million grant from Qatar Research, Development and Innovation (QRDI) Council to develop the first digital twin in the GCC area that focuses on chronic conditions.Nada Al-Olaqi, Director of Innovation Development and Piloting Programs at QRDI Council said in a statement, “At QRDI Council, we’re proud to support Lillia as they push the boundaries of healthcare innovation with their AI-driven digital twin technology. Through our Technology Development Grant program, we empower pioneering companies like Lillia to bring transformative technology solutions to life, advancing healthcare, enhancing quality of life, and positioning Qatar as a leader in digital transformation. This partnership reinforces our shared commitment to creating a lasting impact for communities both locally and globally.”
